Catalyst Wire Dossier Catalyst Wire Dossier

Vioxx (rofecoxib)

rofecoxib · Merck & Co
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vioxx (rofecoxib), covering 2009-12-11 to 2009-12-11. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study) [Phase 2, Phase 3]

See pricing